Related Experiment Video
Updated: Aug 11, 2026
05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 4, 2010
Clonal origin of recurrent meningiomas
A von Deimling1, J Larson, R Wellenreuther
1Department of Neuropathology, Charité, Humboldt University, Berlin, Germany. andreas.von_deimling@charite.de
Brain Pathology (Zurich, Switzerland)
|October 12, 1999
Summary
Recurrent meningiomas often originate from tumor fragments disseminated during surgery, not independent growth. This study confirms clonality in recurring meningiomas, highlighting risks during resection.
Area of Science:
- Neurosurgery
- Oncology
- Genetics
Background:
- Meningiomas are common primary brain and spinal tumors treated by surgical resection.
- Recurrence is frequent despite surgical advances, but the origin of recurrent tumors remains unclear.
Purpose of the Study:
- To investigate the clonality of recurrent meningiomas relative to primary tumors.
- To determine if recurrences arise from incomplete resection, tumor fragment dissemination, or independent growth.
Main Methods:
- Analysis of X-chromosome inactivation patterns (PGK/AR genes) in primary and recurrent meningiomas from five patients.
- Mutation analysis of the NF2 gene in primary and recurrent meningiomas from a sixth patient.
Main Results:
- All analyzed recurrent meningiomas were clonal with respect to their primary lesions (p<0.01).
- Identical NF2 mutations were found in the primary and all recurrent tumors of the sixth patient.
- Findings strongly indicate a common origin for primary and recurrent meningiomas.
Conclusions:
- Recurrent meningiomas typically arise from tumor cell dissemination during initial surgical resection.
- Meningioma cells have a potential for seeding during surgical procedures, necessitating careful surgical technique.
More Related Videos
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...